"Pharmaceutical Headlines" national pick four batch list outflow 2021 Yangtze River Delta drug procurement alliance will be launched

(2020/12/09) First vaccination on protective effects FDA releases detailed evaluation of Pfizer/BioNTech's new crown vaccine; Internet healthcare: trends in hospital scenarios after medicare is included; and how does metformin affect lung cancer survival? IARC's involvement in large-scale research to accumulate new evidence... (Click on the title, you can get the original text) "Medicine 1st time" the four batch list officially flowed out! 2021 Yangtze River Delta Drug Procurement Alliance will be officially launched! On December 8th, the day after the national symposium on centralized drug procurement, the list of four batches quietly flowed out of the country.
the list of 90 products, according to the number of QCE, basically in line with the industry before the evaluation of three that is automatically triggered collection of ideas.
the same time, the relevant product rules are more alternative.
: The Big Year, it's really coming! The FDA will hold a meeting of the Vaccines and Biologics Advisory Committee (VRBPAC) on December 10 to review BNT162b2, a candidate new crown vaccine jointly developed by Pfizer/BioNTech.
, the FDA published on its official website an internal scientist's assessment of BNT162b2's Emergency Use Authorization (EUA) application.
headlines: Further away from getting FDA emergency use authorization? "Mufu Diary" Internet Medical: The trend of medical insurance into the hospital scene with the Internet medical treatment into the medical insurance reimbursement, the development of the market has entered a new stage.
, since all Medicare reimbursements are based entirely on offline health insurance, the impact of health insurance on Internet health care still requires an observation of the actual number and cost of hospitals.
, with the real needs of users and the disclosure of actual costs, future trends in the market will be clarified to a certain extent.
: In the future, third-party platforms will continue to create prescriptions through their own Internet hospitals, but this will still be an out-of-the-box market.
the impact of metformin on lung cancer survival? IARC participated in large-scale studies to accumulate new evidence that diabetes is one of the most common underlying chronic diseases in lung cancer patients.
studies have observed that metformin has a positive impact on survival in lung cancer patients with combined diabetes.
clinical trials in patients with non-diabetic lung cancer did not reach a consistent conclusion.
, a team of researchers from the World Health Organization's International Agency for Research on Cancer (IARC), has developed new evidence for a large-scale population study at the national level.
study found that metformin was associated with improved survival rates in all lung cancer patients, especially in patients with local (TNM phase II-III) lung squamous cancer.
: Classic old drug "cross-border" benefits more patients.